KUSH PARMAR - 08 Jun 2023 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Director, 10%+ Owner
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Issuer symbol
TRDA
Transactions as of
08 Jun 2023
Transactions value $
$0
Form type
4
Filing time
12 Jun 2023, 16:06:35 UTC
Previous filing
19 May 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRDA Stock Option (Right to Buy) Award $0 +16K $0.00 16K 08 Jun 2023 Common Stock 16K $14.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 8, 2023 (the "Vesting Start Date") or (ii) the Issuer's next annual meeting of stockholders.